We are live on
!
Find out more
BCC
Bridge City Capital Portfolio holdings
AUM
$361M
1-Year Est. Return
38.29%
This Fund
S&P 500
This Quarter
Est. Return
+7.84%
1 Year Est. Return
+38.29%
3 Year Est. Return
+76.88%
5 Year Est. Return
+81.43%
10 Year Est. Return
–
AUM
$361M
AUM Growth
+$20.6M
(+6%)
Cap. Flow
+$12.8M
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
114
New
6
Increased
40
Reduced
62
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Addus HomeCare
ADUS
|
+$4.85M |
| 2 |
TG Therapeutics
TGTX
|
+$2.7M |
| 3 |
Pacira BioSciences
PCRX
|
+$2.61M |
| 4 |
Amphastar Pharmaceuticals
AMPH
|
+$2.44M |
| 5 |
PSIX
Power Solutions International
PSIX
|
+$2.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harmony Biosciences
HRMY
|
+$8.87M |
| 2 |
Rogers Corp
ROG
|
+$2.25M |
| 3 |
SPS Commerce
SPSC
|
+$2.15M |
| 4 |
American Eagle Outfitters
AEO
|
+$2.11M |
| 5 |
Photronics
PLAB
|
+$1.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.34% |
| 2 | Healthcare | 26.82% |
| 3 | Industrials | 16.61% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Financials | 6.18% |
Similar funds
PPG
VWM
PWC
DWAM
MCM
PI
PWM
SWM
Bridge City Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Bridge City Capital held 114 positions worth $361M, up 6% from $340M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bridge City Capital deployed $12.8M of net new capital in Q1 2026, opening 6 new positions and adding to 40 existing holdings. Its largest new stake was TG Therapeutics: 90,634 shares worth $3.01M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was MACOM Technology Solutions, an estimated $1.73M trimmed.
- Bridge City Capital's largest Q1 2026 buy was TG Therapeutics: 90,634 shares worth $3.01M.
- Bridge City Capital added most to Addus HomeCare in Q1 2026, an estimated $4.85M increase.
- Bridge City Capital's biggest Q1 2026 reduction was MACOM Technology Solutions, cutting an estimated $1.73M.
- Bridge City Capital fully exited Harmony Biosciences in Q1 2026, selling an estimated $8.87M.
- Bridge City Capital's ten largest holdings make up 25% of its $361M portfolio in Q1 2026.
- Bridge City Capital opened 6 new positions and closed 6 in Q1 2026.
- Bridge City Capital's portfolio value rose 6% quarter-over-quarter to $361M.
Based on Bridge City Capital's 13F filing for Q1 2026, filed 13 May 2026.